Chaplin; David J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chaplin; David J..The latest application filed is for "compositions and methods for inhibition of cathepsins".

Company Profile

1.14.19

Chaplin; David J. - Watlington GB
Chaplin; David J. - San Francisco CA
Chaplin; David J. - Oxford GB
Chaplin; David J. - US
Chaplin; David J. - Richmond CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of VDAS to enhance immunomodulating therapies against tumors Grant 11,419,934 - Chaplin , et al. August 23, 2	2022-08-23
Use Of Vdas To Enhance Immunomodulating Therapies Against Tumors App 20190008956 - CHAPLIN; David J. ; et al.	2019-01-10
Compositions And Methods For Inhibition Of Cathepsins App 20190010173 - Pinney; Kevin G. ; et al.	2019-01-10
Compositions and methods for inhibition of cathepsins Grant 9,873,668 - Chaplin , et al. January 23, 2	2018-01-23
Compositions And Methods For Inhibition Of Cathepsins App 20160368869 - Chaplin; David J. ; et al.	2016-12-22
Compositions and methods for inhibition of cathepsins Grant 9,458,103 - Chaplin , et al. October 4, 2	2016-10-04
Functionalized stilbene derivatives as improved vascular targeting agents Grant RE45,907 - Chaplin , et al. March 1, 2	2016-03-01
Functionalized stilbene derivatives as improved vascular targeting agents Grant RE45,720 - Chaplin , et al. October 6, 2	2015-10-06
Method and Composition for Alleviating Tumor Symptoms App 20150141349 - Davis; Peter David ; et al.	2015-05-21
Compositions and Methods for Inhibition of Cathepsins App 20150031915 - Chaplin; David J. ; et al.	2015-01-29
Compositions and methods for inhibition of cathepsins Grant 8,877,967 - Chaplin , et al. November 4, 2	2014-11-04
Compositions and Methods for Inhibition of Cathepsins App 20130296605 - Chaplin; David J. ; et al.	2013-11-07
Compositions and methods with enhanced therapeutic activity Grant 8,198,302 - Chaplin , et al. June 12, 2	2012-06-12
Chromene-containing compounds with anti-tubulin and vascular targeting activity Grant 7,456,214 - Pinney , et al. November 25, 2	2008-11-25
Functionalized stilbene derivatives as improved vascular targeting agents Grant 7,384,925 - Chaplin , et al. June 10, 2	2008-06-10
Tubulin binding ligands and corresponding prodrug constructs Grant 7,091,240 - Pinney , et al. August 15, 2	2006-08-15
Tubulin binding agents and corresponding prodrug constructs App 20060142252 - Pinney; Kevin G. ; et al.	2006-06-29
Method of administering split doses of a vascular targeting agent App 20060135625 - Chaplin; David J. ; et al.	2006-06-22
Compositions and methods for use in targeting vascular destruction App 20060100179 - Pero; Ronald W. ; et al.	2006-05-11
Tubulin binding agents and corresponding prodrug constructs Grant 7,001,926 - Pinney , et al. February 21, 2	2006-02-21
Functionalized stilbene derivatives as improved vascular targeting agents App 20060035868 - Chaplin; David J. ; et al.	2006-02-16
Chromene-containing compounds with anti-tubulin and vascular targeting activity App 20050245489 - Pinney, Kevin G. ; et al.	2005-11-03
Chromene-containing compounds with anti-tubulin and vascular targeting activity App 20050245490 - Pinney, Kevin G. ; et al.	2005-11-03
Methods for modulating tumor growth and metastasis App 20050209310 - Chaplin, David J. ; et al.	2005-09-22
Functionalized stilbene derivatives as improved vascular targeting agents Grant 6,919,324 - Chaplin , et al. July 19, 2	2005-07-19
Compositions and methods with enhanced therapeutic activity App 20040242696 - Chaplin, David J. ; et al.	2004-12-02
Method of administering split doses of a vascular targeting agent App 20040067255 - Chaplin, David J. ; et al.	2004-04-08
Tubulin binding agents and corresponding prodrug constructs App 20040043969 - Pinney, Kevin G. ; et al.	2004-03-04
Tubulin binding ligands and corresponding prodrug constructs App 20040044059 - Pinney, Kevin G. ; et al.	2004-03-04
Functionalized stilbene derivatives as improved vascular targeting agents App 20030149003 - Chaplin, David J. ; et al.	2003-08-07
Platinum complexes with one radiosensitizing ligand Grant 5,026,694 - Skov , et al. June 25, 1	1991-06-25
Platinum complexes with one radiosensitizing ligand Grant 4,921,963 - Skov , et al. May 1, 1	1990-05-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.